(CTN News) _ In an effort to combat mosquito-borne dengue fever, Cuban authorities have made strides toward the development of a vaccine.
According to Eduardo Martinez, president of the BioCubaFarma Biotech Conglomerate, when making the announcement.
He stated that a diagnostic system could be developed in order to detect the disease as soon as the primary symptoms appear.
In the last ten years, Cuban scientists have worked tirelessly to find a vaccine against dengue and determined to develop one that induces a mobile response towards the virus over the course of time.
It is expected that they will have it as soon as possible.
It is a commercial product.
In addition, Martinez reported that Cuba already has a brand new quick diagnostic system that may assist with health protocols by detecting the illness as soon as the affected person feels the first symptoms and even when reinfection happens.
As a result, he said, different therapies may be available to sufferers in order to prevent the event of the illness and the death it may result in.
This is a mosquito-borne disease that occurs in tropical and subtropical regions of the world, and it is associated with dengue fever.
As a result of the mild form of dengue fever, a person may have a fever and flu-like symptoms, but the extreme form of dengue fever, also known as dengue hemorrhagic fever, can result in critical bleeding and even death.
In the course of a year, there are tens of millions of cases of dengue an infection across the globe.
Southeast Asia, Latin America, Africa, and the islands of the western Pacific are the main regions where dengue fever is prevalent.
In spite of the fact, the disease has been spreading to new areas, including native outbreaks in Europe and the southern states of the United States.